{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:22:44Z","timestamp":1787318564730,"version":"build-2736575974"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.neuropharm.2005.06.007","type":"journal-article","created":{"date-parts":[[2005,7,15]],"date-time":"2005-07-15T09:34:03Z","timestamp":1121420043000},"page":"167-178","source":"Crossref","is-referenced-by-count":110,"special_numbering":"S","title":["Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats"],"prefix":"10.1016","volume":"49","author":[{"given":"Anton Y.","family":"Bespalov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga A.","family":"Dravolina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilya","family":"Sukhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Blokhina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Zvartau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Danysz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"van Heeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2005.06.007_bib1","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1037\/0735-7044.110.6.1397","article-title":"Sensitization to the psychomotor stimulant effects of amphetamine: modulation by associative learning","volume":"110","author":"Anagnostaras","year":"1996","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s002130050774","article-title":"Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine","volume":"140","author":"Arroyo","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib3","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/sj.npp.1300381","article-title":"mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior","volume":"29","author":"Backstrom","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib4","first-page":"S70","article-title":"Schedule-induced reinstatement of nicotine self-administration in rats: effects of nicotine and bupropion","volume":"29","author":"Bespalov","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib5","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1038\/sj.npp.1300540","article-title":"The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety","volume":"29","author":"Busse","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0091-3057(01)00676-1","article-title":"Cue dependency of nicotine self-administration and smoking","volume":"70","author":"Caggiula","year":"2001","journal-title":"Pharmacology Biochemistry & Behavior"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00213-002-1156-5","article-title":"Environmental stimuli promote the acquisition of nicotine self-administration in rats","volume":"163","author":"Caggiula","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib8","series-title":"Behavioural Neuroscience: A Practical Approach, Vol. 2","first-page":"117","article-title":"Intravenous drug self-administration techniques in animals","author":"Caine","year":"1993"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/0306-4522(89)90012-2","article-title":"Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats","volume":"28","author":"Carboni","year":"1989","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib10","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nn0901-873","article-title":"Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice","volume":"4","author":"Chiamulera","year":"2001","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brainresrev.2004.08.005","article-title":"Cue reactivity in nicotine and tobacco dependence: a \u201cmultiple-action\u201d model of nicotine as a primary reinforcement and as an enhancer of the effects of smoking-associated stimuli","volume":"48","author":"Chiamulera","year":"2005","journal-title":"Brain Research Reviews"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1176\/ajp.156.1.11","article-title":"Limbic activation during cue-induced cocaine craving","volume":"156","author":"Childress","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib13","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/jm025570j","article-title":"3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity","volume":"46","author":"Cosford","year":"2003","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib14","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0149-7634(83)90010-6","article-title":"A reinterpretation of schedule-induced behaviors based on a systematic analysis of behavior","volume":"7","author":"Cook","year":"1983","journal-title":"Neuroscience Biobehavioral Reviews"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib15","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3758\/BF03209574","article-title":"The origin and functions of adjunctive behavior","volume":"5","author":"Falk","year":"1977","journal-title":"Animal Learning and Behavior"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0376-8716(98)00084-2","article-title":"Solvay Award address. Drug abuse as an adjunctive behavior","volume":"52","author":"Falk","year":"1998","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0006-8993(93)90477-5","article-title":"Conditioned increases in mesolimbic dopamine overflow by stimuli associated with cocaine","volume":"629","author":"Fontana","year":"1993","journal-title":"Brain Research"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib18","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib19","first-page":"1448","article-title":"Residence times and half-lives of nicotine metabolites in rat brain after acute peripheral administration of [2\u2032-(14)C]nicotine","volume":"27","author":"Ghosheh","year":"1999","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1901\/jeab.1970.14-33","article-title":"Conditioned nalorphine-induced abstinence changes: persistence in post morphine-dependent monkeys","volume":"14","author":"Goldberg","year":"1970","journal-title":"Journal of the Experimental Analysis of Behavior"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/syn.10261","article-title":"Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo","volume":"50","author":"Heidbreder","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib22","series-title":"Glutamate and Addiction","year":"2003"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00213-004-2069-2","article-title":"Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats","volume":"179","author":"Kenny","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib24","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1037\/0735-7044.115.5.1086","article-title":"Conditioned reinstatement of drug-seeking behavior with a discrete compound stimulus classically conditioned with intravenous cocaine","volume":"115","author":"Kruzich","year":"2001","journal-title":"Behavioral Neuroscience"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib25","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0149-7634(03)00073-3","article-title":"Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review","volume":"27","author":"Lu","year":"2003","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0893-133X(98)00080-3","article-title":"Effects of contingent and non-contingent cocaine on drug-seeking behavior measured using a second-order schedule of cocaine reinforcement in rats","volume":"20","author":"Markou","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF02244907","article-title":"Animal models of drug craving","volume":"112","author":"Markou","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib28","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/syn.10166","article-title":"The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse","volume":"47","author":"McGeehan","year":"2003","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib29","first-page":"754","article-title":"Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse","volume":"7","author":"Meil","year":"1996","journal-title":"Behavioural Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib30","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/0893-133X(95)00274-H","article-title":"Preclinical evaluation of pharmacotherapies for treatment of cocaine and opioid abuse using drug self-administration procedures","volume":"14","author":"Mello","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1901\/jeab.2001.76-43","article-title":"Variable-ratio versus variable-interval schedules: response rate, resistance to change, and preference","volume":"76","author":"Nevin","year":"2001","journal-title":"Journal of the Experimental Analysis of Behavior"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/026988119801200103","article-title":"Conditioning factors in drug abuse: can they explain compulsion?","volume":"12","author":"O'Brien","year":"1998","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib33","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.bjp.0703715","article-title":"Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism","volume":"131","author":"O'Leary","year":"2000","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/sj.npp.1300524","article-title":"Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats","volume":"30","author":"Paterson","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00213-004-2070-9","article-title":"The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats","volume":"179","author":"Paterson","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib36","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-003-1432-z","article-title":"The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice","volume":"167","author":"Paterson","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib37","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0028-3908(02)00309-X","article-title":"Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist","volume":"43","author":"Popik","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000139274","article-title":"Distribution and retention of nicotine and its metabolite, cotinine, in the rat as a function of time","volume":"50","author":"Sastry","year":"1995","journal-title":"Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00213-002-1251-7","article-title":"Cocaine-seeking behavior after extended cocaine-free periods in rats: role of conditioned stimuli","volume":"168","author":"Semenova","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00213-002-1224-x","article-title":"The reinstatement model of drug relapse: history, methodology and major findings","volume":"168","author":"Shaham","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib41","series-title":"The Psychopharmacology of Addiction","first-page":"73","article-title":"Drug anticipation and drug tolerance","author":"Siegel","year":"1988"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0091-3057(85)90487-3","article-title":"Intravenous self-administration of nicotine: with and without schedule-induction","volume":"22","author":"Slifer","year":"1985","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1037\/0033-295X.91.2.251","article-title":"Role of unconditioned and conditioned drug effects in the self-administration of opiates and stimulants","volume":"91","author":"Stewart","year":"1984","journal-title":"Psychological Review"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib44","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.bjp.0703923","article-title":"Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist","volume":"132","author":"Tatarczynska","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib45","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2004.07.056","article-title":"Antagonism at metabotropic glutamate 5 receptors inhibits nicotine- and cocaine-taking behaviours and prevents nicotine-triggered relapse to nicotine-seeking","volume":"499","author":"Tessari","year":"2004","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib46","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0091-3057(76)90114-3","article-title":"Schedule induced behavior: a review of its generality, determinants and pharmacological data","volume":"5","author":"Wallace","year":"1976","journal-title":"Pharmacology Biochemistry and Behavior"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01249232","article-title":"Conditioning of morphine-induced locomotor activity and stereotyped behaviour in rats","volume":"78","author":"Walter","year":"1989","journal-title":"Journal of Neural Transmission (General Section)"},{"key":"10.1016\/j.neuropharm.2005.06.007_bib48","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0893-133X(01)00238-X","article-title":"Enduring resistance to extinction of cocaine-seeking behavior induced by drug-related cues","volume":"25","author":"Weiss","year":"2001","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805002212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390805002212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T08:55:43Z","timestamp":1548320143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390805002212"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":48,"alternative-id":["S0028390805002212"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2005.06.007","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}